MYLAN expects that 2012 will be
another year of growth for the
company, predicting revenue for
the year to sit between US$6.8
billion and US$7.2 billion
(representing 14% annual growth).
“Our continued growth in 2012
will be driven by the anticipated
launch of approximately 650 global
products, including more than 100
in the US with brand sales of more
than $40 billion,” said company
CEO Heather Bresch.
“We intend to continue to
broaden our geographic footprint
and expand our presence in India
by launching a commercial
business there during the first half
of this year, bringing us 1.2 billion
people closer to our goal of
reaching the world’s 7 billion,” she
addedThe above article was sent to subscribers in Pharmacy Daily's issue from 24 Feb 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Feb 12
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.